PMID- 35948810 OWN - NLM STAT- MEDLINE DCOM- 20220926 LR - 20220926 IS - 1568-5608 (Electronic) IS - 0925-4692 (Linking) VI - 30 IP - 5 DP - 2022 Oct TI - Tumor necrosis factor alpha (TNF-alpha) blockage reduces acute inflammation and delayed wound healing in oral ulcer of rats. PG - 1781-1798 LID - 10.1007/s10787-022-01046-3 [doi] AB - Oral traumatic ulcers (OTU) are common in dental routine, and the control of proinflammatory cytokines, such as the tumor necrosis factor-alpha (TNF-alpha), may interfere with OTU repair. Our aim was to evaluate the role of TNF-alpha in the healing process of OTU in rats. Wistar male rats were divided into six groups: a control-group (treated with 0.1 mL/kg of saline) and five groups treated with anti-TNF-alpha infliximab (INF) at 1, 3, 5, 7, and 10 mg/kg immediately before OTU production. The animals were weighed (day 0) and euthanized on days 1, 3, 7, 14 and 21 after ulceration. The ulcers were clinically measured, and the mucosa samples were histologically (scores 0-4), histochemically (collagen assay (pircrosirius)), histomorphometrically (cell counting), and immunohistochemically (TNF-alpha, alpha-smooth-muscle-actin (alpha-SMA), monocyte-chemoattractive-protein-1 (MCP-1), interleukin-8 (IL-8), and fibroblast-growth-factor (FGF)) analyzed. The Evans blue assay was used to measure the vascular permeability. ANOVA-1-2-way/Bonferroni, Kruskal-Wallis/Dunn, and correlation analyses were performed (GraphPad Prism 5.0, p < 0.05). High doses of INF reduced the OTU area (p = 0.043), body mass loss (p = 0.023), vascular permeability (p < 0.001), and reduced delayed histologic scores (p < 0.05), polymorphonuclear (p < 0.001) and mononuclear (p < 0.001) cells, blood vessel counting (p = 0.006), and total (p < 0.001), type-I (p = 0.018), and type-III (p < 0.001) collagen. INF treatment reduced TNF-alpha immunostaining and delayed MPC-1, FGF, and alpha-SMA expression, with little/none influence in IL-8 immunostaining. TNF-alpha blockage by INF reduced acute inflammation in OTU but delayed cell migration and wound healing. CI - (c) 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. FAU - Freitas, Milena Oliveira AU - Freitas MO AD - Department of Dentistry, Unichristus, Rua Joao Adolfo Gurgel, 133, Coco, Fortaleza, Ceara, CEP 60192-345, Brazil. AD - Division of Oral Pathology, Department of Dental Clinic, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceara, Brazil. FAU - Fonseca, Alline Pereira Rodrigues AU - Fonseca APR AD - Department of Dentistry, Unichristus, Rua Joao Adolfo Gurgel, 133, Coco, Fortaleza, Ceara, CEP 60192-345, Brazil. FAU - de Aguiar, Maria Thaynara AU - de Aguiar MT AD - Department of Dentistry, Unichristus, Rua Joao Adolfo Gurgel, 133, Coco, Fortaleza, Ceara, CEP 60192-345, Brazil. FAU - Dias, Camila Costa AU - Dias CC AD - Department of Dentistry, Unichristus, Rua Joao Adolfo Gurgel, 133, Coco, Fortaleza, Ceara, CEP 60192-345, Brazil. FAU - Avelar, Rafael Linard AU - Avelar RL AD - Division of Oral Pathology, Department of Dental Clinic, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceara, Brazil. FAU - Sousa, Fabricio Bitu AU - Sousa FB AD - Department of Dentistry, Unichristus, Rua Joao Adolfo Gurgel, 133, Coco, Fortaleza, Ceara, CEP 60192-345, Brazil. AD - Division of Oral Pathology, Department of Dental Clinic, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceara, Brazil. FAU - Alves, Ana Paula Negreiros Nunes AU - Alves APNN AD - Division of Oral Pathology, Department of Dental Clinic, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceara, Brazil. FAU - de Barros Silva, Paulo Goberlanio AU - de Barros Silva PG AUID- ORCID: 0000-0002-1513-9027 AD - Department of Dentistry, Unichristus, Rua Joao Adolfo Gurgel, 133, Coco, Fortaleza, Ceara, CEP 60192-345, Brazil. paulo_goberlanio@yahoo.com.br. AD - Division of Oral Pathology, Department of Dental Clinic, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceara, Fortaleza, Ceara, Brazil. paulo_goberlanio@yahoo.com.br. LA - eng PT - Journal Article DEP - 20220810 PL - Switzerland TA - Inflammopharmacology JT - Inflammopharmacology JID - 9112626 RN - 0 (Actins) RN - 0 (Cytokines) RN - 0 (Interleukin-8) RN - 0 (Tumor Necrosis Factor Inhibitors) RN - 0 (Tumor Necrosis Factor-alpha) RN - 45PG892GO1 (Evans Blue) RN - 9007-34-5 (Collagen) RN - B72HH48FLU (Infliximab) SB - IM MH - Actins MH - Animals MH - Collagen MH - Cytokines MH - Evans Blue/therapeutic use MH - Inflammation/drug therapy MH - Infliximab/pharmacology/therapeutic use MH - Interleukin-8/therapeutic use MH - Male MH - *Oral Ulcer/drug therapy/pathology MH - Rats MH - Rats, Wistar MH - Tumor Necrosis Factor Inhibitors MH - *Tumor Necrosis Factor-alpha/metabolism MH - Ulcer MH - Wound Healing OTO - NOTNLM OT - Inflammation OT - Infliximab OT - Oral ulcer OT - Tumor necrosis factor tumoral-alpha OT - Wound healing EDAT- 2022/08/11 06:00 MHDA- 2022/09/28 06:00 CRDT- 2022/08/10 23:30 PHST- 2022/06/20 00:00 [received] PHST- 2022/07/26 00:00 [accepted] PHST- 2022/08/11 06:00 [pubmed] PHST- 2022/09/28 06:00 [medline] PHST- 2022/08/10 23:30 [entrez] AID - 10.1007/s10787-022-01046-3 [pii] AID - 10.1007/s10787-022-01046-3 [doi] PST - ppublish SO - Inflammopharmacology. 2022 Oct;30(5):1781-1798. doi: 10.1007/s10787-022-01046-3. Epub 2022 Aug 10.